Eupraxia Pharmaceuticals Reports Second Quarter 2024 Financial Results
Go back to Eupraxia Pharmaceuticals Reports Second Quarter 2024 Financial Results| (NASDAQ: EPRX) | Delayed: 6.37 -0.09 (1.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.46 | 52 Week High | $ | |||
| Open | $6.46 | 52 Week Low | $ | |||
| Day High | $6.53 | P/E | N/A | |||
| Day Low | $6.34 | EPS | $ | |||
| Volume | 23,791 | |||||
| (NASDAQ: EPRX) | Delayed: 6.37 -0.09 (1.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.46 | 52 Week High | $ | |||
| Open | $6.46 | 52 Week Low | $ | |||
| Day High | $6.53 | P/E | N/A | |||
| Day Low | $6.34 | EPS | $ | |||
| Volume | 23,791 | |||||

